Clinical Research

Title: Specimen Collection Study to Evaluate Biomarkers in Subjects with Cancer

Purpose of Study: Blood and tissue (depending on cohort) will be collected to evaluate biomarkers that may be associated with cancer, including tumor burden and/or tumor characteristics and to support subsequent assay development activities.

Protocol Summary: This study is evaluating biomarkers related to cancer. Biomarkers are biological features found in the body that may be related to cancer risk, detection, and remaining or returning cancer. The purpose of this research study is to collect blood and tissue specimens to analyze biomarkers related to cancer as potential targets for future cancer screening tests.

Basic Eligibility Criteria:

Inclusion:

Treatment Naïve Cohorts

• Cancer Diagnosis: Subjects with a histologic diagnosis of a solid tumor or a diagnosis of a hematologic malignancy.

OR

• Cancer Suspicion: Subjects with a clinical suspicion of a primary malignancy of the pancreas, bladder, kidney/renal pelvis, testicular or ovarian cancer, or melanoma based on imaging, tumor markers, signs and/or symptoms.

Recurrent Cancer Cohorts

• Recurrent Cancer Diagnosis: Subjects with a confirmed recurrence of a previously diagnosed solid tumor or hematologic malignancy.
• Recurrent Cancer Suspicion: Subjects with a clinical suspicion of recurrence of the pancreas, bladder, kidney/renal pelvis, testicular or ovarian cancer, or melanoma based on imaging, tumor markers, signs and/or symptoms.

Exclusion:

Treatment Naïve Cohorts

• Recent, prior (recurrent), or concurrent multiple cancer diagnosis.
• Any treatment for the current cancer diagnosis. Subject may not have started any form of cancer therapy to treat their malignancy.

Recurrent Cancer Cohorts

• Subject is still undergoing therapy for their original cancer diagnosis.
• Subject has already started first line systemic therapy or radiotherapy for recurrent cancer

For More Information

If you are interested in this research study, please email the Cancer Care Northwest Research Department at research@ccnw.net for more information. Be sure to include:

• Your name
• Phone number & if we can leave a voice message at this number
• Trial number(s) you are interested in
• Name and city of clinic where you are currently being treated